The price.Above
$171 the blended value is a SELL; at
$140 or less it is a BUY.
The exit multiple.At 8x FY2030E EBITDA the blend sits on the SELL line, and below it is a SELL; the Gordon value alone is already one.
Capex at the low end.The 2027 plan is $5–6 billion; spending less for the same growth lifts the value.
Pre-print triggers to move off the provisional SELL, and Q3
| Toward HOLD if | Reported |
| Comparable sales growth | above 4.5% | 5.6% |
| Gross margin excluding refunds | above 29.5% | 29.4% |
| Full-year EPS guide | raised | $10.65–$11.40 |
| Price (blend SELL above) | $171 | $161.45 |
Current stance: HOLD on the 50/50 blend of the Gordon and exit-multiple values.